Many medical decisions involve issues that make decision making difficult including trade-offs between alternatives that offer different sets of advantages and disadvantages, uncertainty about future outcomes, insufficient data, practical constraints, the involvement of multiple stakeholders, and emotional reactions to difficult circumstances.
A variety of multi-criteria decision analysis (MCDA) methods have been developed to help individuals and groups make quality decisions in circumstances like these and move from decisional uncertainty to action. We are exploring how these methods can be used to help patients and providers work together to make good decisions in challenging circumstances.
We are actively seeking men with newly diagnosed prostate cancer who have not started treatment.
Click here for a close-captioned version of the video.
We are currently studying the use of a multi-criteria decision dashboard to help men with newly diagnosed low or intermediate risk prostate cancer choose the most appropriate treatment. There is no single best treatment option. Rather, several treatment options are recommended that offer different sets of advantages and disadvantages. Choosing an option therefore involves making preference-based trade-offs between the pros and cons of the options available.
Click here for further information.
Prostate cancer survivor's study
This study is open to all men with a history of prostate cancer who are willing to review the dashboard and give us feedback about what works, what doesn’t work, and how the dashboard can be improved. The study is also open to spouses, partners and other immediate family members of men with a history of prostate cancer.
Click here for additional information.
These studies are supported by grant U48DP005026 Rochester Prevention Research Center SIP 14-014 from the US Centers for Disease Control (CDC)
MCDM-Med is a collaboration between the University of Rochester and Us TOO International